Balance Sheet Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
803.17 ^USD	+2.49%		+2.25%	+4.06%

13/02	HSBC Adjusts Price Target on Regeneron Pharmaceuticals to $990 From $985, Maintains Buy Rating	MT
12/02	Regeneron Pharmaceuticals Insider Sold Shares Worth $1,585,058, According to a Recent SEC Filing	MT

b8537cf9b.KK3KquCjx12OAYusO9qCTBaYENl2O_rAJWYe2YeTVa8.QtT_mLiS9jTncOTcUL_1f0XxII0QUp2wQwdmuNXQEpoe4pKfuc-DD8dbyg

Published financial data: REGENERON PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.58TCr	1.18TCr	1.26TCr	1.37TCr	1.36TCr
Other Revenues, Total	28Cr	37Cr	54Cr	52Cr	70Cr
Total Revenues	1.61TCr	1.22TCr	1.31TCr	1.42TCr	1.43TCr
Cost of Goods Sold, Total	534.56Cr	515.29Cr	625.48Cr	710.25Cr	795.09Cr
Gross Profit	1.07TCr	702Cr	686.24Cr	709.95Cr	639.2Cr
Selling General & Admin Expenses, Total	182.49Cr	211.59Cr	263.13Cr	295.44Cr	270Cr
Other Operating Expenses	-4.56Cr	-8.99Cr	-21L	-	-1Cr
Other Operating Expenses, Total	177.93Cr	202.6Cr	262.92Cr	295.44Cr	269Cr
Operating Income	894.68Cr	499.4Cr	423.32Cr	414.51Cr	370.2Cr
Interest Expense, Total	-5.73Cr	-5.94Cr	-7.3Cr	-5.52Cr	-4.38Cr
Interest And Investment Income	-	16Cr	50Cr	71Cr	72Cr
Net Interest Expenses	-5.73Cr	10Cr	42Cr	66Cr	67Cr
Currency Exchange Gains (Loss)	-	-	-1.29Cr	-5L	24L
Other Non Operating Income (Expenses)	5.02Cr	5.9Cr	-2Cr	1.58Cr	99Cr
EBT, Excl. Unusual Items	893.97Cr	515.37Cr	462.32Cr	481.66Cr	536.54Cr
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	39Cr	-3.98Cr	-24Cr	12Cr	-1.06Cr
In Process R&D Expenses	-	-26Cr	-19Cr	-10Cr	-12Cr
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-5.34Cr	-
EBT, Incl. Unusual Items	932.58Cr	485.88Cr	419.93Cr	477.99Cr	523.07Cr
Income Tax Expense	125.05Cr	52Cr	25Cr	37Cr	73Cr
Earnings From Continuing Operations	807.53Cr	433.84Cr	395.36Cr	441.26Cr	450.49Cr
Net Income to Company	807.53Cr	433.84Cr	395.36Cr	441.26Cr	450.49Cr
Net Income - (IS)	807.53Cr	433.84Cr	395.36Cr	441.26Cr	450.49Cr
Net Income to Common Incl Extra Items	807.53Cr	433.84Cr	395.36Cr	441.26Cr	450.49Cr
Net Income to Common Excl. Extra Items	807.53Cr	433.84Cr	395.36Cr	441.26Cr	450.49Cr
Per Share Items
Net EPS - Basic	76.4	40.51	37.05	40.9	43.07
Basic EPS - Continuing Operations	76.4	40.51	37.05	40.9	43.07
Basic Weighted Average Shares Outstanding	11Cr	11Cr	11Cr	11Cr	10Cr
Net EPS - Diluted	71.97	38.22	34.77	38.34	41.48
Diluted EPS - Continuing Operations	71.97	38.22	34.77	38.34	41.48
Diluted Weighted Average Shares Outstanding	11Cr	11Cr	11Cr	12Cr	11Cr
Normalized Basic EPS	52.86	30.08	27.08	27.9	32.06
Normalized Diluted EPS	49.8	28.38	25.41	26.15	30.88
Dividend Per Share	-	-	-	-	3.52
Payout Ratio	-	-	-	-	8.22
American Depositary Receipts Ratio (ADR)	0.02	0.02	0.02	0.02	0.02
Supplemental Items
EBITDA	923.3Cr	533.54Cr	465.42Cr	462.8Cr	424.57Cr
EBITA	894.68Cr	503.16Cr	432.54Cr	427.4Cr	388.08Cr
EBIT	894.68Cr	499.4Cr	423.32Cr	414.51Cr	370.2Cr
EBITDAR	-	-	467.34Cr	466.45Cr	428.15Cr
Total Revenues (As Reported)	1.61TCr	1.22TCr	1.31TCr	1.42TCr	1.43TCr
Effective Tax Rate - (Ratio)	13.41	10.71	5.85	7.68	13.88
Current Domestic Taxes	143.6Cr	98Cr	68Cr	108.15Cr	103.21Cr
Current Foreign Taxes	-3.84Cr	29Cr	41Cr	4.31Cr	48Cr
Total Current Taxes	139.76Cr	126.68Cr	108.35Cr	112.46Cr	151.12Cr
Deferred Domestic Taxes	-42Cr	-80Cr	-84Cr	-94Cr	-86Cr
Deferred Foreign Taxes	28Cr	5.4Cr	32L	18Cr	7.53Cr
Total Deferred Taxes	-15Cr	-75Cr	-84Cr	-76Cr	-79Cr
Normalized Net Income	558.73Cr	322.11Cr	288.95Cr	301.04Cr	335.34Cr
Interest on Long-Term Debt	5.63Cr	6.59Cr	8.94Cr	9.05Cr	8.35Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	340.42Cr	412.13Cr	480.14Cr	542.38Cr	612.28Cr
Net Rental Expense, Total	-	-	1.92Cr	3.65Cr	3.58Cr
Imputed Operating Lease Interest Expense	-	-	40.33L	56.27L	42.44L
Imputed Operating Lease Depreciation	-	-	1.52Cr	3.09Cr	3.16Cr
Stock-Based Comp., COGS (Total)	32Cr	41Cr	49Cr	54Cr	55Cr
Stock-Based Comp., SG&A Exp. (Total)	21Cr	26Cr	31Cr	36Cr	36Cr
Stock-Based Comp., Other (Total)	7.18Cr	6.18Cr	8.92Cr	8.4Cr	8.54Cr
Total Stock-Based Compensation	60Cr	72Cr	88Cr	98Cr	99Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	288.56Cr	310.59Cr	273Cr	248.82Cr	311.81Cr
Short Term Investments	280.91Cr	463.64Cr	811.48Cr	652.43Cr	548.71Cr
Total Cash And Short Term Investments	569.47Cr	774.23Cr	1.08TCr	901.25Cr	860.52Cr
Accounts Receivable, Total	505.9Cr	358.6Cr	531.73Cr	584.41Cr	574.11Cr
Other Receivables	98Cr	174.27Cr	35Cr	37Cr	-
Total Receivables	603.65Cr	532.87Cr	566.73Cr	621.19Cr	574.11Cr
Inventory	195.13Cr	240.19Cr	258.05Cr	308.73Cr	320.08Cr
Prepaid Expenses	33Cr	41Cr	39Cr	35Cr	47Cr
Restricted Cash	-	-	-	8L	56L
Total Current Assets	1.4TCr	1.59TCr	1.95TCr	1.87TCr	1.8TCr
Gross Property Plant And Equipment	488.03Cr	543.22Cr	624.78Cr	718.24Cr	804.93Cr
Accumulated Depreciation	-139.81Cr	-166.92Cr	-202.34Cr	-236.53Cr	-268.31Cr
Net Property Plant And Equipment	348.22Cr	376.3Cr	422.44Cr	481.71Cr	536.62Cr
Long-term Investments	687.8Cr	664.01Cr	547.08Cr	905.99Cr	1.06TCr
Other Intangibles, Total	-	92Cr	103.86Cr	114.86Cr	125.74Cr
Deferred Tax Assets Long-Term	88Cr	172.37Cr	257.54Cr	331.41Cr	407.72Cr
Other Long-Term Assets, Total	18Cr	29Cr	29Cr	76Cr	124.14Cr
Total Assets	2.54TCr	2.92TCr	3.31TCr	3.78TCr	4.06TCr
Liabilities
Accounts Payable, Total	56Cr	59Cr	61Cr	79Cr	94Cr
Accrued Expenses, Total	159.31Cr	206.34Cr	231.63Cr	228.36Cr	283.86Cr
Current Portion of Leases	72Cr	-	1.9Cr	3.03Cr	3.78Cr
Current Income Taxes Payable	33Cr	3L	-	21Cr	-
Unearned Revenue Current, Total	44Cr	48Cr	48Cr	63Cr	55Cr
Other Current Liabilities	29Cr	1.05Cr	-	-	-
Total Current Liabilities	393.25Cr	314.13Cr	342.34Cr	394.43Cr	436.84Cr
Long-Term Debt	198Cr	198.14Cr	198.29Cr	198.44Cr	198.59Cr
Long-Term Leases	-	72Cr	79Cr	92Cr	95Cr
Unearned Revenue Non Current	7.33Cr	6.98Cr	13Cr	19Cr	21Cr
Other Non Current Liabilities	68Cr	64Cr	79Cr	136.73Cr	178.98Cr
Total Liabilities	666.6Cr	655.05Cr	710.71Cr	840.58Cr	930.18Cr
Common Stock, Total	1L	1L	1L	1L	1L
Additional Paid In Capital	808.75Cr	994.93Cr	1.14TCr	1.29TCr	1.4TCr
Retained Earnings	1.9TCr	2.33TCr	2.73TCr	3.17TCr	3.58TCr
Treasury Stock	-826.09Cr	-1.04TCr	-1.26TCr	-1.52TCr	-1.86TCr
Comprehensive Income and Other	-2.62Cr	-24Cr	-8.09Cr	-79L	7.75Cr
Total Common Equity	1.88TCr	2.27TCr	2.6TCr	2.94TCr	3.13TCr
Total Equity	1.88TCr	2.27TCr	2.6TCr	2.94TCr	3.13TCr
Total Liabilities And Equity	2.54TCr	2.92TCr	3.31TCr	3.78TCr	4.06TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	11Cr	11Cr	11Cr	11Cr	10Cr
ECS Total Common Shares Outstanding	11Cr	11Cr	11Cr	11Cr	10Cr
Book Value / Share	176.11	211.81	242.47	274.08	304.65
Tangible Book Value	1.88TCr	2.17TCr	2.49TCr	2.82TCr	3TCr
Tangible Book Value Per Share	176.11	203.26	232.78	263.35	292.39
Total Debt	269.97Cr	270.14Cr	279.06Cr	293.88Cr	297.27Cr
Net Debt	-983.3Cr	-1.16TCr	-1.35TCr	-1.5TCr	-1.59TCr
Debt Equivalent Oper. Leases	-	-	15Cr	29Cr	29Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	72Cr	82Cr	79Cr	88Cr	64Cr
Inventories - Work In Process, Total	71Cr	96Cr	112.18Cr	134.23Cr	164.16Cr
Inventories - Finished Goods, Total	7.37Cr	9.86Cr	15Cr	14Cr	19Cr
Inventories - Others	45Cr	52Cr	52Cr	73Cr	73Cr
Land - (BS)	25Cr	26Cr	28Cr	29Cr	28Cr
Buildings, Total	208.85Cr	227Cr	242.31Cr	257.32Cr	310.59Cr
Machinery, Total	166.22Cr	180.29Cr	194.01Cr	214.91Cr	228.54Cr
Full Time Employees	10.37T	11.85T	13.45T	15.11T	15.41T

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	807.53Cr	433.84Cr	395.36Cr	441.26Cr	450.49Cr
Depreciation & Amortization - CF	29Cr	30Cr	33Cr	35Cr	36Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	3.76Cr	9.22Cr	13Cr	18Cr
Depreciation & Amortization, Total	29Cr	34Cr	42Cr	48Cr	54Cr
(Gain) Loss on Sale of Investments - (CF)	-39Cr	3.68Cr	27Cr	-12Cr	-95Cr
Asset Writedown & Restructuring Costs	-	20Cr	-	1.26Cr	-
Stock-Based Compensation (CF)	60Cr	72Cr	88Cr	98Cr	99Cr
Other Operating Activities, Total	42Cr	-38Cr	-84Cr	-73Cr	-65Cr
Change In Accounts Receivable	-192.74Cr	71Cr	-34Cr	-55Cr	50Cr
Change In Inventories	-49Cr	-70Cr	-27Cr	-62Cr	-28Cr
Change In Accounts Payable	87Cr	-14Cr	60Cr	74Cr	74Cr
Change in Unearned Revenues	-12Cr	3.24Cr	3.79Cr	23Cr	-5.17Cr
Change in Other Net Operating Assets	-24Cr	-15Cr	-12Cr	-41Cr	-38Cr
Cash from Operations	708.13Cr	501.49Cr	459.4Cr	442.05Cr	497.89Cr
Capital Expenditure	-55Cr	-59Cr	-72Cr	-76Cr	-90Cr
Sale of Property, Plant, and Equipment	-	-	-	2.01Cr	-
Cash Acquisitions	-	-23Cr	-5.49Cr	-1.65Cr	-33L
Sale (Purchase) of Intangible assets	-	-102.68Cr	-21Cr	-13Cr	-32Cr
Investment in Marketable and Equity Securities, Total	-483.28Cr	-193.74Cr	-220.38Cr	-159.01Cr	59Cr
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-538.47Cr	-378.46Cr	-318.51Cr	-246.81Cr	-63Cr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	167.23Cr	151.95Cr	114.55Cr	146.53Cr	64Cr
Repurchase of Common Stock	-267.81Cr	-252.85Cr	-293.56Cr	-363.24Cr	-397.07Cr
Common Dividends Paid	-	-	-	-	-37Cr
Common & Preferred Stock Dividends Paid	-	-	-	-	-37Cr
Other Financing Activities, Total	-	-	-	-3.34Cr	-1.03Cr
Cash from Financing	-100.58Cr	-100.9Cr	-179.01Cr	-220.05Cr	-371.54Cr
Foreign Exchange Rate Adjustments	-	-	-4L	-7L	3L
Net Change in Cash	69Cr	22Cr	-38Cr	-25Cr	63Cr
Supplemental Items
Cash Interest Paid	5.58Cr	5.37Cr	7.31Cr	5.26Cr	4.16Cr
Cash Income Tax Paid (Refund)	121.84Cr	150.24Cr	87Cr	74Cr	-
Levered Free Cash Flow	427.92Cr	264.05Cr	276.26Cr	263.59Cr	325.84Cr
Unlevered Free Cash Flow	431.5Cr	267.76Cr	280.82Cr	267.04Cr	328.58Cr
Change In Net Working Capital	161.27Cr	-11Cr	22Cr	50Cr	-65Cr
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	26.25	11.42	8.49	7.31	5.91
Return on Total Capital	31.78	13.33	9.76	8.49	6.96
Return On Equity %	54.21	20.94	16.26	15.95	14.86
Return on Common Equity	54.21	20.94	16.26	15.95	14.86
Margin Analysis
Gross Profit Margin %	66.74	57.67	52.32	49.99	44.57
SG&A Margin	11.35	17.38	20.06	20.8	18.82
EBITDA Margin %	57.45	43.83	35.48	32.59	29.6
EBITA Margin %	55.67	41.33	32.98	30.09	27.06
EBIT Margin %	55.67	41.03	32.27	29.19	25.81
Income From Continuing Operations Margin %	50.25	35.64	30.14	31.07	31.41
Net Income Margin %	50.25	35.64	30.14	31.07	31.41
Net Avail. For Common Margin %	50.25	35.64	30.14	31.07	31.41
Normalized Net Income Margin	34.76	26.46	22.03	21.2	23.38
Levered Free Cash Flow Margin	26.63	21.69	21.06	18.56	22.72
Unlevered Free Cash Flow Margin	26.85	22	21.41	18.8	22.91
Asset Turnover
Asset Turnover	0.75	0.45	0.42	0.4	0.37
Fixed Assets Turnover	4.79	3.36	3.26	3.14	2.82
Receivables Turnover (Average Receivables)	3.87	2.73	2.43	2.46	2.28
Inventory Turnover (Average Inventory)	2.76	2.37	2.51	2.51	2.53
Short Term Liquidity
Current Ratio	3.56	5.06	5.69	4.73	4.13
Quick Ratio	2.98	4.16	4.82	3.86	3.28
Operating Cash Flow to Current Liabilities	1.8	1.6	1.34	1.12	1.14
Days Sales Outstanding (Average Receivables)	94.44	133.62	150	148.98	159.92
Days Outstanding Inventory (Average Inventory)	132.05	154.18	145.37	146.03	144.33
Average Days Payable Outstanding	35.26	37.56	33.92	33.58	39.12
Cash Conversion Cycle (Average Days)	191.23	250.23	261.45	261.44	265.14
Long Term Solvency
Total Debt/Equity	14.38	11.92	10.74	10.01	9.51
Total Debt / Total Capital	12.58	10.65	9.7	9.1	8.68
LT Debt/Equity	10.55	11.92	10.67	9.91	9.39
Long-Term Debt / Total Capital	9.22	10.65	9.64	9.01	8.57
Total Liabilities / Total Assets	26.21	22.42	21.48	22.26	22.93
EBIT / Interest Expense	156.14	84.07	57.99	75.09	84.52
EBITDA / Interest Expense	161.13	89.82	64.02	84.5	97.75
(EBITDA - Capex) / Interest Expense	151.5	79.89	54.18	70.81	77.24
Total Debt / EBITDA	0.29	0.51	0.6	0.63	0.69
Net Debt / EBITDA	-1.06	-2.18	-2.88	-3.21	-3.71
Total Debt / (EBITDA - Capex)	0.31	0.57	0.71	0.75	0.88
Net Debt / (EBITDA - Capex)	-1.13	-2.45	-3.4	-3.83	-4.7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	89.14	-24.26	7.76	8.27	0.99
Gross Profit, 1 Yr. Growth %	131.06	-34.84	-2.25	3.46	-9.97
EBITDA, 1 Yr. Growth %	142.18	-42.51	-12.77	-0.56	-8.26
EBITA, 1 Yr. Growth %	150.15	-44.06	-14.04	-1.19	-9.2
EBIT, 1 Yr. Growth %	150.15	-44.48	-15.23	-2.08	-10.69
Earnings From Cont. Operations, 1 Yr. Growth %	129.86	-46.28	-8.87	11.61	2.09
Net Income, 1 Yr. Growth %	129.86	-46.28	-8.87	11.61	2.09
Normalized Net Income, 1 Yr. Growth %	149.34	-42.66	-10.29	4.18	11.39
Diluted EPS Before Extra, 1 Yr. Growth %	135.81	-46.89	-9.03	10.27	8.19
Accounts Receivable, 1 Yr. Growth %	62.56	-29.12	5.86	10.29	-7.58
Inventory, 1 Yr. Growth %	1.81	23.09	7.44	19.64	3.68
Net Property, Plant and Equip., 1 Yr. Growth %	8.09	8.06	10.18	14.03	11.4
Total Assets, 1 Yr. Growth %	48.19	14.86	13.23	14.14	7.41
Tangible Book Value, 1 Yr. Growth %	70.23	15.92	14.65	13.12	6.36
Common Equity, 1 Yr. Growth %	70.23	20.75	14.6	13.02	6.48
Cash From Operations, 1 Yr. Growth %	170.47	-29.18	-8.39	-3.78	12.63
Capital Expenditures, 1 Yr. Growth %	-10.2	6.92	21.78	5.19	18.85
Levered Free Cash Flow, 1 Yr. Growth %	276.49	-38.72	5.12	-4.59	23.62
Unlevered Free Cash Flow, 1 Yr. Growth %	268.12	-38.37	5.37	-4.91	23.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	56.55	19.69	-9.66	8.01	4.57
Gross Profit, 2 Yr. CAGR %	79.14	21.82	-20.19	0.56	-3.49
EBITDA, 2 Yr. CAGR %	95.32	16.96	-29.18	-6.86	-4.49
EBITA, 2 Yr. CAGR %	101.21	17.18	-30.65	-7.84	-5.28
EBIT, 2 Yr. CAGR %	101.21	16.74	-31.4	-8.89	-6.48
Earnings From Cont. Operations, 2 Yr. CAGR %	95.36	11.13	-30.03	0.85	6.74
Net Income, 2 Yr. CAGR %	95.36	11.13	-30.03	0.85	6.74
Normalized Net Income, 2 Yr. CAGR %	96.69	17.98	-28.28	-3.33	7.68
Diluted EPS Before Extra, 2 Yr. CAGR %	97.45	11.91	-30.49	0.16	9.22
Accounts Receivable, 2 Yr. CAGR %	37.05	7.35	2.52	7.86	4.09
Inventory, 2 Yr. CAGR %	17.41	11.95	15	13.37	11.37
Net Property, Plant and Equip., 2 Yr. CAGR %	9.76	8.08	10.14	12.09	12.71
Total Assets, 2 Yr. CAGR %	31.07	30.47	14.04	13.69	10.73
Tangible Book Value, 2 Yr. CAGR %	30.09	40.45	15.28	13.88	9.69
Common Equity, 2 Yr. CAGR %	30.09	43.37	17.64	13.81	9.7
Cash From Operations, 2 Yr. CAGR %	70.71	38.4	-19.46	-6.11	4.1
Capital Expenditures, 2 Yr. CAGR %	13.34	-2.01	14.11	13.18	11.81
Levered Free Cash Flow, 2 Yr. CAGR %	73.35	48.86	-19.93	0.15	8.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	72.94	47.71	-19.61	0.09	8.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	46.18	22.9	15.57	-4.04	5.62
Gross Profit, 3 Yr. CAGR %	48.74	28.06	13.2	-12.98	-3.08
EBITDA, 3 Yr. CAGR %	50.98	30.15	6.07	-20.7	-7.33
EBITA, 3 Yr. CAGR %	52.26	31.56	5.68	-21.97	-8.29
EBIT, 3 Yr. CAGR %	52.26	31.23	4.93	-22.76	-9.5
Earnings From Cont. Operations, 3 Yr. CAGR %	48.93	27.04	4.02	-18.25	1.26
Net Income, 3 Yr. CAGR %	48.93	27.04	4.02	-18.25	1.26
Normalized Net Income, 3 Yr. CAGR %	51.02	30.65	7.68	-18.77	1.35
Diluted EPS Before Extra, 3 Yr. CAGR %	50.08	27.45	4.44	-18.94	2.77
Accounts Receivable, 3 Yr. CAGR %	30.58	10.01	19.55	4.93	4.55
Inventory, 3 Yr. CAGR %	19.23	19.27	10.42	16.52	10.04
Net Property, Plant and Equip., 3 Yr. CAGR %	10.57	9.19	9.45	11.42	11.86
Total Assets, 3 Yr. CAGR %	29.42	25.43	24.45	14.08	11.56
Tangible Book Value, 3 Yr. CAGR %	28.93	25.17	31.26	14.56	11.32
Common Equity, 3 Yr. CAGR %	28.93	26.9	33.06	16.08	11.31
Cash From Operations, 3 Yr. CAGR %	47.76	27.32	20.62	-14.54	-0.24
Capital Expenditures, 3 Yr. CAGR %	12.94	11.16	5.35	11.05	15.04
Levered Free Cash Flow, 3 Yr. CAGR %	46.75	22.86	32.35	-15.11	7.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	46.53	22.89	31.78	-14.98	7.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	27.02	15.7	20.58	16.71	11.04
Gross Profit, 5 Yr. CAGR %	33.72	15.6	16.06	16.26	6.21
EBITDA, 5 Yr. CAGR %	45.1	19.11	11.65	13.84	1.71
EBITA, 5 Yr. CAGR %	46.39	19.33	11.28	14.1	1.15
EBIT, 5 Yr. CAGR %	46.39	19.15	10.8	13.41	0.2
Earnings From Cont. Operations, 5 Yr. CAGR %	55.25	29.34	10.09	15.84	5.1
Net Income, 5 Yr. CAGR %	55.25	29.34	10.09	15.84	5.1
Normalized Net Income, 5 Yr. CAGR %	46.17	19.92	12.24	15.82	7.7
Diluted EPS Before Extra, 5 Yr. CAGR %	56.35	29.88	10.31	15.74	6.33
Accounts Receivable, 5 Yr. CAGR %	25.71	11.88	18.54	16.76	13.03
Inventory, 5 Yr. CAGR %	37.34	27.03	17.52	16.88	10.8
Net Property, Plant and Equip., 5 Yr. CAGR %	10.82	9.79	10.4	10.76	10.74
Total Assets, 5 Yr. CAGR %	29.54	27.23	23.03	20.59	18.77
Tangible Book Value, 5 Yr. CAGR %	33.36	28.76	23.28	20.53	22.16
Common Equity, 5 Yr. CAGR %	33.36	29.83	24.29	21.49	23.17
Cash From Operations, 5 Yr. CAGR %	36.65	30.86	15.92	12.71	13.72
Capital Expenditures, 5 Yr. CAGR %	1.52	16.7	13.41	11.96	7.89
Levered Free Cash Flow, 5 Yr. CAGR %	33.17	23.91	15.33	13.11	22.28
Unlevered Free Cash Flow, 5 Yr. CAGR %	33.28	23.83	15.41	13.1	21.77